NanoViricides Announces $2.5 Million Financing in a Registered Direct Offering
SHELTON, Conn., Feb.
February 27, 2019 | https://www.growthcapitalist.com/2019/02/nanoviricides-announces-2-5-million-financing-in-a-registered-direct-offering/Your search for nanoviricides returned 7 results
NanoViricides Raises $5M in Conv Debt Issue at 35% Premium
NanoViricides, Inc. (NNVC) announced that it has raised $5,000,000 in a Convertible Debentures transaction.
July 4, 2014 | https://www.growthcapitalist.com/2014/07/nanoviricides-raises-5m-conv-debt-issue-35-premium/NanoViricides Takes Short Seller Hit
NanoViricides (NNVC), a biotech company that has raised $42 million through PIPE and registered equity private placements in the last 12 months, including a $20 million registered direct offering managed by Midtown Partners and Chardan Capital Markets in late January, experienced a hit of up to 28% in its stock on Tuesday, Feb.
February 11, 2014 | https://www.growthcapitalist.com/2014/02/nanoviricides-takes-short-seller-hit/NanoViricides Raises $20M in RDO at 13% Discount via Chardan Capital, Midtown Partners
NanoViricides, Inc. (NNVC) announced that it has raised $20,030,246 in a Registered Direct transaction.
January 26, 2014 | https://www.growthcapitalist.com/2014/01/nanoviricides-raises-20m-in-rdo-at-13-discount-via-chardan-capital-midtown-partners/